The European Medicines Agency approved the Pfizer-BioNTech Covid-19 vaccine for use in 12 to 15-year olds on Friday. “The CHMP concluded that the benefits of Comirnaty in this age group outweigh the risks,” the EMA said in a statement. Dummy injectionIt found that of the 1,005 children who received the vaccine, none developed Covid-19. “This means that, in this study, the vaccine was 100 per cent effective at preventing Covid-19,” the EMA said. “In low and lower-middle income countries, Covid-19 vaccine supply has not been enough to even immunise healthcare workers, and hospitals are being inundated with people that need lifesaving care urgently,” he told a press conference.

Source: The Irish Times May 28, 2021 14:42 UTC